Immune Therapeutics Pink Sheet Forecast - Rate Of Daily Change

IMUNDelisted Stock  USD 0.06  0  4.76%   
Immune Pink Sheet Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast Immune Therapeutics stock prices and determine the direction of Immune Therapeutics's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Immune Therapeutics' historical fundamentals, such as revenue growth or operating cash flow patterns.
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in employment.
  
Immune Therapeutics has current Rate Of Daily Change of 0.95.
Most investors in Immune Therapeutics cannot accurately predict what will happen the next trading day because, historically, stock markets tend to be unpredictable and even illogical. Modeling turbulent structures requires applying different statistical methods, techniques, and algorithms to find hidden data structures or patterns within the Immune Therapeutics' time series price data and predict how it will affect future prices. One of these methodologies is forecasting, which interprets Immune Therapeutics' price structures and extracts relationships that further increase the generated results' accuracy.
Rate Of Daily Change (RDOC) indicator calculates rate of change of a given period over the current closing price of Immune Therapeutics.
Check Immune Therapeutics VolatilityBacktest Immune TherapeuticsInformation Ratio  

Immune Therapeutics Trading Date Momentum

On April 24 2024 Immune Therapeutics was traded for  0.06  at the closing time. The top price for the day was 0.06  and the lowest listed price was  0.06 . There was no trading activity during the period 0.0. Lack of trading volume on April 24, 2024 did not cause price change. The trading delta at closing time against the current closing price is 5.00% .
The rate of daily change can indicate whether a given asset was oversold or over brought during a given period.
Compare Immune Therapeutics to competition

Immune Therapeutics Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Immune Therapeutics pink sheet to make a market-neutral strategy. Peer analysis of Immune Therapeutics could also be used in its relative valuation, which is a method of valuing Immune Therapeutics by comparing valuation metrics with similar companies.
 Risk & Return  Correlation

Immune Therapeutics Market Strength Events

Market strength indicators help investors to evaluate how Immune Therapeutics pink sheet reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Immune Therapeutics shares will generate the highest return on investment. By undertsting and applying Immune Therapeutics pink sheet market strength indicators, traders can identify Immune Therapeutics entry and exit signals to maximize returns.

Immune Therapeutics Risk Indicators

The analysis of Immune Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Immune Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting immune pink sheet prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Immune Therapeutics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Immune Therapeutics' short interest history, or implied volatility extrapolated from Immune Therapeutics options trading.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in employment.
You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.

Other Consideration for investing in Immune Pink Sheet

If you are still planning to invest in Immune Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Immune Therapeutics' history and understand the potential risks before investing.
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
CEOs Directory
Screen CEOs from public companies around the world
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets